Company Filing History:
Years Active: 2012
Title: Lydia G Thebeau: Innovator in Antiviral Vaccine Development
Introduction
Lydia G Thebeau is a notable inventor based in Eureka, MO (US), recognized for her contributions to the field of antiviral vaccines. With a focus on enhancing immune responses, her work has significant implications for public health and disease prevention.
Latest Patents
Lydia G Thebeau holds a patent for a groundbreaking invention titled "Virus-expressing host costimulation molecules." This antiviral vaccine encodes costimulation molecules aimed at increasing the immune response to specific viruses. In her research, she demonstrated the importance of these molecules in generating HSV-specific immunity, particularly in mice lacking both B7-1 and B7-2. The study revealed that the expression of B7-1 or B7-2 by replication-defective HSV could enhance its immunogenicity and protective capacity, thereby partially reconstituting immune responses to HSV.
Career Highlights
Lydia G Thebeau is affiliated with Saint Louis University, where she continues her research and development in the field of immunology. Her innovative approach to vaccine development has positioned her as a key figure in the fight against viral infections.
Collaborations
Lydia has collaborated with esteemed colleagues, including Lynda Anne Morrison and Jane E Schrimpf, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Lydia G Thebeau's work in antiviral vaccine development exemplifies the critical role of inventors in advancing medical science. Her contributions not only enhance our understanding of immune responses but also pave the way for future innovations in vaccine technology.